BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kim SO, Han SY, Baek YH, Lee SW, Han JS, Kim BG, Cho JH, Nam KJ. Splenic infarction associated with sorafenib use in a hepatocellular carcinoma patient. World J Gastroenterol 2011; 17(2): 267-270 [PMID: 21246003 DOI: 10.3748/wjg.v17.i2.267]
URL: https://www.wjgnet.com/1007-9327/full/v17/i2/267.htm
Number Citing Articles
1
Constantin A Dasanu, Premkumar Padmanabhan, Bernard A. Clark, Christine Do. Cardiovascular toxicity associated with small molecule tyrosine kinase inhibitors currently in clinical useExpert Opinion on Drug Safety 2012; 11(3): 445 doi: 10.1517/14740338.2012.672971
2
Chieh-Ching Yen, Chih-Kai Wang, Shou-Yen Chen, Shi-Ying Gao, Hsiang-Yun Lo, Chip-Jin Ng, Chung-Hsien Chaou. Risk assessment and prognostic analysis of patients with splenic infarction in emergency department: a multicenter retrospective studyScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-00897-0
3
Nicholas A. Barber, Wais Afzal, Mojtaba Akhtari. Hematologic toxicities of small molecule tyrosine kinase inhibitorsTargeted Oncology 2011; 6(4): 203 doi: 10.1007/s11523-011-0202-9
4
Yosuke Aihara, Hitoshi Yoshiji, Masaharu Yamazaki, Yasuhide Ikenaka, Ryuichi Noguchi, Chie Morioka, Kosuke Kaji, Haruki Tastumi, Keisuke Nakanishi, Maiko Nakamura, Junichi Yamao, Masahisa Toyohara, Akira Mitoro, Masayoshi Sawai, Motoyuki Yoshida, Masao Fujimoto, Masahito Uemura, Hiroshi Fukui. A case of severe acalculous cholecystitis associated with sorafenib treatment for advanced hepatocellular carcinomaWorld Journal of Gastrointestinal Oncology 2012; 4(5): 115-118 doi: 10.4251/wjgo.v4.i5.115
5
Chitra Viswanathan, Mylene Truong, Tara Sagebiel, Naveen Garg, Priya Bhosale. Imaging of Chemotherapy-related Iatrogenic Abdominal and Pelvic ConditionsRadiologic Clinics of North America 2014; 52(5): 1029 doi: 10.1016/j.rcl.2014.05.008
6
Chitra Viswanathan. Imaging of Complications and Toxicity following Tumor TherapyMedical Radiology 2014; : 277 doi: 10.1007/174_2014_1049